New UK authorisation procedure will draw on international drug approvals
Drug Discovery World
JANUARY 4, 2024
The UK Medicines and Healthcare products Regulatory Agency’s (MHRA) new International Recognition procedure (IRP) will allow it to draw on the expertise of regulators in other countries when authorising medicines.
Let's personalize your content